文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌

粪菌移植影响复发性艰难梭菌感染受者中的促癌性大肠杆菌

Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
PubMed 文献 · Gastroenterology · 2021-06-11

该回顾性队列纳入49例接受粪菌移植(FMT)的复发性艰难梭菌感染(rCDI)患者及供体样本,筛查粪便宏基因组中产聚酮合酶(pks)大肠杆菌。rCDI患者pks丰度高于健康供体,FMT后pks状态取决于供体pks状态,pks+大肠杆菌持续或清除与供体相关,但供体至患者传播不常见。

要点

  • rCDI患者pks+大肠杆菌的携带率和丰度均高于健康供体。
  • FMT后患者pks状态与所用供体悬液的pks状态相关。
  • pks+患者中pks+大肠杆菌的持续或清除与供体pks状态相关。

核心结论

  • FMT可影响rCDI患者pks+大肠杆菌的持续或清除,但供体至患者的pks+大肠杆菌传播不太可能。

研究设计与样本

  • 回顾性队列研究,纳入49例接受FMT的rCDI患者及匹配供体样本,筛查粪便宏基因组中pks+大肠杆菌。

主要发现

  • rCDI患者FMT前pks岛阳性27/49(55%),中位丰度0.46 RPKM,高于健康供体的11/38样本(29%)、中位0.01 RPKM(P < .001)。
  • rCDI患者pks岛阳性率高于健康供体(P = .026)。
  • FMT后患者pks状态取决于供体悬液pks状态(P = .046)。
  • pks+患者中pks+大肠杆菌持续(8/9例)或清除(13/18例)与供体pks状态相关(P = .004)。

临床怎么用

  • 对于接受FMT的rCDI患者,供体pks状态可能影响患者pks+大肠杆菌的持续或清除,选择供体时可考虑此因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with multiple recurrent Clostridioides difficile infection (rCDI) have a disturbed gut microbiota that can be restored by fecal microbiota transplantation (FMT). Despite extensive screening, healthy feces donors may carry bacteria in their intestinal tract that could have long-term health effects, such as potentially procarcinogenic polyketide synthase-positive (pks+) Escherichia coli. Here, we aim to determine whether the pks abundance and persistence of pks+E coli is influenced by pks status of the donor feces. METHODS: In a cohort of 49 patients with rCDI treated with FMT and matching donor samples-the largest cohort of its kind, to our knowledge-we retrospectively screened fecal metagenomes for pks+E coli and compared the presence of pks in patients before and after treatment and to their respective donors. RESULTS: The pks island was more prevalent (P = .026) and abundant (P < .001) in patients with rCDI (pre-FMT, 27 of 49 [55%]; median, 0.46 reads per kilobase per million [RPKM] pks) than in healthy donors (3 of 8 donors [37.5%], 11 of 38 samples [29%]; median, 0.01 RPKM pks). The pks status of patients post-FMT depended on the pks status of the donor suspension with which the patient was treated (P = .046). Particularly, persistence (8 of 9 cases) or clearance (13 of 18) of pks+E coli in pks+ patients was correlated to pks in the donor (P = .004). CONCLUSIONS: We conclude that FMT contributes to pks+E coli persistence or eradication in patients with rCDI but that donor-to-patient transmission of pks+E coli is unlikely.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Nooij S, Ducarmon QR, Laros JFJ, et al. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients. Gastroenterology. 2021. PMID: 34126062. doi:10.1053/j.gastro.2021.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。